Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating costs and expenses
Research and development	$ 7,354,708	$ 2,281,363
Research and development - licenses acquired (including stock-based compensation)	174,782	607,562
Compensation and related expenses (including stock-based compensation)	3,036,034	1,454,478
Professional fees (including stock-based compensation)	2,703,837	2,478,493
Rent	46,871	25,871
Other general and administrative expenses	785,208	454,207
Total operating expenses	14,101,440	7,301,974
Loss from operations	(14,101,440)	(7,301,974)
Other income (expenses)
Other income (expenses), net	(212,265)	104,158
Total other income (expenses)	(212,265)	104,158
Net loss	(14,313,705)	(7,197,816)
Other comprehensive gain (loss)
Foreign currency translation adjustment	32,937	(15,351)
Total comprehensive loss	$ (14,280,768)	$ (7,213,167)
Net loss per share applicable to common stockholders - basic and diluted (in Dollars per share)	$ (0.64)	$ (0.58)
Weighted average number of common shares outstanding, basic and diluted (in Shares)	22,330,093	12,362,833